| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 16, 2024 | SCLX Scilex Holding Co | Shah Jaisim | See Remarks | Buy | 30,000 | $0.99 | $29,751.00 | +63.4% | -48.3% | -56.3% | |
| Oct 15, 2024 | KNSA Kiniksa Pharmaceuticals International, Plc | Tessari Eben | Chief Operating Officer | Sell | 17,000 | $26.87 | $456,790.00 | -13.4% | -32.9% | +43.6% | |
| Oct 15, 2024 | HIMS Hims & Hers Health, Inc. | Boughton Soleil | Chief Legal Officer | Sell | 2,339 | $20.41 | $47,738.99 | -1.3% | +13.6% | +175.3% | |
| Oct 15, 2024 | HIMS Hims & Hers Health, Inc. | Chi Michael | Chief Commercial Officer | Sell | 75,493 | $22.00 | $1,660,846.00 | -28.0% | +13.6% | +175.3% | |
| Oct 14, 2024 | HIMS Hims & Hers Health, Inc. | Okupe Oluyemi55 | Chief Financial Officer | Sell | 269,739 | $20.31 | $5,478,228.72 | -10.8% | +26.3% | +163.5% | |
| Oct 14, 2024 | ANIP Ani Pharmaceuticals Inc | Cook Meredith50 | Sr. VP, General Counsel &Sec. | Sell | 250 | $57.19 | $14,297.50 | -0.4% | -7.8% | +51.7% | |
| Oct 14, 2024 | LQDA Liquidia Corp | Schundler Russell58 | General Counsel | Sell | 2,576 | $11.11 | $28,613.44 | -0.5% | +5.6% | +104.5% | |
| Oct 14, 2024 | LQDA Liquidia Corp | Moomaw Scott | Chief Commercial Officer | Sell | 1,527 | $11.11 | $16,961.46 | -1.0% | +5.6% | +104.5% | |
| Oct 14, 2024 | ETST Earth Science Tech, Inc. | Sanchez Yovan Arturo | Director | Buy | 100,000 | $0.14 | $14,000.00 | +9.1% | - | - | |
| Oct 14, 2024 | LQDA Liquidia Corp | Jeffs Roger66 | Chief Executive Officer | Sell | 8,053 | $11.11 | $89,450.31 | -1.0% | +5.6% | +104.5% | |
| Oct 14, 2024 | UTHR United Therapeutics Corp | Edgemond James | CFO And Treasurer | Sell | 7,792 | $355.88 | $2,773,016.96 | -24.2% | +1.6% | +21.4% | |
| Oct 14, 2024 | LQDA Liquidia Corp | Kaseta Michael57 | CFO And COO | Sell | 3,892 | $11.11 | $43,231.17 | -1.2% | +5.6% | +104.5% | |
| Oct 14, 2024 | LQDA Liquidia Corp | Saggar Rajeev | Chief Medical Officer | Sell | 2,260 | $11.11 | $25,103.40 | -1.1% | +5.6% | +104.5% | |
| Oct 14, 2024 | LQDA Liquidia Corp | Adair Jason | Chief Business Officer | Sell | 1,146 | $11.11 | $12,729.42 | -1.0% | +5.6% | +104.5% | |
| Oct 10, 2024 | ETST Earth Science Tech, Inc. | Saumat Giorgio R. | CEO | Buy | 76,371 | $0.16 | $12,071.65 | - | - | - | |
| Oct 8, 2024 | ETON Eton Pharmaceuticals, Inc. | Opaleye Management Inc.60 | 10% Owner | Buy | 62,070 | $6.99 | $434,136.74 | +0.7% | +64.3% | +182.8% | |
| Oct 7, 2024 | UTHR United Therapeutics Corp | Edgemond James | CFO And Treasurer | Sell | 7,794 | $355.54 | $2,771,078.76 | -26.0% | +1.6% | +30.6% | |
| Oct 7, 2024 | HIMS Hims & Hers Health, Inc. | Okupe Oluyemi55 | Chief Financial Officer | Sell | 9,868 | $19.96 | $196,991.92 | -4.8% | +38.4% | +198.2% | |
| Oct 7, 2024 | HIMS Hims & Hers Health, Inc. | Baird Melissa | Chief Operating Officer | Sell | 58,750 | $19.57 | $1,149,625.29 | -4.4% | +38.4% | +198.2% | |
| Oct 3, 2024 | LFCR Lifecore Biomedical, Inc. \de\ | Wynnefield Partners Small Cap Value LP I65 | 10% Owner | Buy | 292,683 | $4.10 | $1,200,000.30 | +6.6% | +41.6% | +48.4% | |
| Oct 3, 2024 | LFCR Lifecore Biomedical, Inc. \de\ | Kiper Christopher S | Director, 10% Owner | Buy | 1,463,414 | $4.10 | $5,999,997.40 | +49.8% | +41.6% | +48.4% | |
| Oct 3, 2024 | NBIX Neurocrine Biosciences Inc | Boyer David W.51 | Chief Corp. Affairs Officer | Sell | 1,295 | $113.66 | $147,189.70 | -77.5% | +23.2% | +22.5% | |
| Oct 3, 2024 | BIOA Bioage Labs, Inc. | Pande Vijay Satyanand | Director | Buy | 219,195 | $19.75 | $4,329,019.37 | +7.3% | -73.3% | -73.1% | |
| Oct 3, 2024 | BTAI Bioxcel Therapeutics, Inc. | Steinhart Richard I87 | Chief Financial Officer | Sell | 7,175 | $0.55 | $3,946.25 | -26.1% | -28.7% | -71.3% | |
| Oct 3, 2024 | BTAI Bioxcel Therapeutics, Inc. | Wiley Matthew T.82 | Chief Commercial Officer | Sell | 6,272 | $0.55 | $3,449.60 | -24.8% | -28.7% | -71.3% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.